Healthcare Global Enterprises Limited’s subsidiary, HCG Manavata Oncology LLP, has entered into an agreement to acquire a 26% equity stake in Epic Vighnaharta Renewable Energy Private Limited (EVRE) for ₹38 lakh. This strategic move allows the oncology provider to secure captive power supply from a new renewable energy source, aligning with operational sustainability goals while diversifying into clean energy infrastructure through its subsidiary structure.

The transaction was disclosed on August 04, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The filing confirms that the deal does not constitute a related-party transaction, as neither the promoter group nor other group companies hold direct interests in EVRE beyond the indirect stake held via the LLP.

Transaction Structure

The acquisition involves the subscription of 3,80,000 equity shares of ₹10 each, representing 26% of EVRE’s total share capital on a fully diluted basis. The entire consideration of ₹38 lakh is structured as a cash payment. Upon completion, HCG Manavata Oncology LLP will hold the minority stake directly, giving Healthcare Global Enterprises Limited an indirect interest of up to 26% in the renewable energy developer.

Strategic Rationale

EVRE is primarily engaged in power generation from renewable sources and is currently developing a solar power plant in Mangalwedha, District Solapur, Maharashtra. The facility is designed with an initial capacity of 1.3 MWp. By acquiring this stake, HCG Manavata Oncology LLP qualifies as a captive user of the plant, enabling EVRE to supply generated electricity directly to the LLP for its own consumption. This arrangement supports the company’s infrastructure needs while participating in the clean energy development sector.

Target Company Profile

Epic Vighnaharta Renewable Energy Private Limited was incorporated on March 22, 2025, under the Companies Act, 2013. Its registered office is located in Mumbai. As a newly established entity focused on project development, EVRE reported nil revenue from operations for FY26, FY25, and FY24. The company’s authorized share capital stands at ₹1,00,000. No specific governmental approvals are required for the incorporation or this acquisition, aside from standard business licenses.

What the Numbers Show

The acquisition highlights a shift toward vertical integration in utility costs for Healthcare Global Enterprises. While the financial outlay of ₹38 lakh is modest relative to the parent company’s scale, the strategic value lies in securing long-term captive power supply. With EVRE reporting no historical revenue, the investment is purely forward-looking, tied to the commissioning of the 1.3 MWp solar plant. This structure minimizes immediate financial risk while locking in potential energy cost savings and sustainability credits for the oncology network.

HealthCare Global Enterprises will host an earnings conference call on Friday, August 7, 2026, at 2:00 PM IST to discuss its unaudited financial results for the quarter ended June 30, 2026 (Q1FY27). The event provides investors with a direct channel to senior management for insights into the company's operational and financial performance during the period. This disclosure is made under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The Board of Directors of HealthCare Global Enterprises considered, approved, and took on record the standalone and consolidated financial results on Thursday, August 6, 2026. The subsequent call allows stakeholders to query management on key drivers behind the reported figures, including revenue trends, margin dynamics, and capital expenditure plans across its network of 25 hospitals in India and Africa.

Conference Call Details

The conference call will begin with a brief presentation by senior management outlining the Q1FY27 results, followed by an interactive question-and-answer session. Participants can join via pre-registration to avoid wait times or through various international dial-in numbers. Investors are advised to register in advance using the provided ExpressJoin link to connect without operator delay.

About HealthCare Global Enterprises

Headquartered in Bengaluru, HealthCare Global Enterprises operates under the brand "HCG" and positions itself as India's largest cancer care provider. With a network spanning India and Africa, the company aims to deliver advanced diagnosis and treatment technologies under one roof. The firm continues to expand its footprint to bring specialized care to broader demographics.

Safe Harbor Statement

This document contains forward-looking statements based on management's beliefs, opinions, and expectations as of the release date. These statements involve risks and uncertainties that are difficult to predict. Readers are cautioned against placing undue reliance on such projections, as the company does not assume any obligation to update them if circumstances change.